Currently there is a lot of interest in circulating tumor cells (CTC’s) as a rich source of biomarkers for the early cancer detection. For these enrichment methods, the detection of cancerous cells is clouded by the presence of many normal cells. Thus there is a need for sensitive somatic mutation detection.
Here Rob Bennett of Thermo Fisher Scientific R&D describes a poster presented at the Advances of Genome Biology and Technology meeting, also available for download.
Download the full poster below.
Now that we are all back from Charlotte, North Carolina, whe... by Swati Kadam, PhD / 11.15.2016Read More
Conferences are so packed that it’s often difficult to... by Swati Kadam, PhD / 05.09.2016Read More